
0:00
5:10
Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.
More episodes from "The Biopharma Pod"



Don't miss an episode of “The Biopharma Pod” and subscribe to it in the GetPodcast app.








